drugset

drugset / Trial / NCT04971577

Efficacy of Simvastatin in Alcoholic Liver Fibrosis

NCT04971577 ↗

Phase 2/3 Recruiting 90 enrolled Anna Cruceta

RandomizedParallel-groupTriple-blindTreatment

Summary

Evaluate the efficacy of simvastatin in reducing liver fibrosis in patients with advanced fibrosis due to alcohol

Timeline

Start: 2022-02-22
Primary completion: 2027-03
Completion: 2027-12

Publications

Luo X, Wang G, Yang L, Hernandez-Gea V. Future research direction of portal hypertension based on Baveno VII. Chin Med J (Engl). 2025 Sep 20;138(18):2268-2282. doi: 10.1097/CM9.0000000000003785. Epub 2025 Aug 18.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Simvastatin	Small molecule	40 mg	—

Indications